The class period for the investor lawsuit against Better Home & Finance Holding Company has been extended to cover purchases from March 13 to August 6, 2026. The lawsuit alleges the company misled investors about the performance and growth of its Tinman AI lending platform, including overstated loan volume targets and undisclosed operational issues. After revealing lower-than-expected loan conversions and partnership problems, the company's stock price dropped 61%. The case is ongoing, with a lead plaintiff deadline of November 20, 2026, and investors who suffered losses are encouraged to participate.
Better Home & Finance Holding Company investor lawsuit deadline approaches, here is Pluang's snapshot of the Financials sector as of Nov 14, 2026 00:32 WIB: Among 142 priced US Financials stocks, 92 rose and 49 fell. Galaxy Digital Inc. (GLXY) dropped 5.27% to USD 14.38 with a balanced 50% sell/buy order split and a typical hold time of 9 days, while BitMine Immersion Technologies Inc. (BMNR) fell 5.20% to USD 17.49 with a shorter hold time of 4 days. CleanSpark Inc. (CLSK) declined 4.68% to USD 6.52 but saw a strong 74% buy order activity and a longer hold time of 24 days.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
